Chronic obstructive pulmonary disease (COPD) is a progressive respiratory disorder characterized by airflow limitation and persistent respiratory symptoms. People with HIV (PWH) are particularly vulnerable to COPD development; PWH have demonstrated both higher rates of COPD and an earlier and more rapid decline in lung function than their seronegative counterparts, even after accounting for differences in cigarette smoking. Factors contributing to this HIV-associated difference include chronic immune activation and inflammation, accelerated aging, a predilection for pulmonary infections, alterations in the lung microbiome, and the interplay between HIV and inhalational toxins. In this review, we discuss what is known about the epidemiology and pathobiology of COPD among PWH and outline screening, diagnostic, prevention, and treatment strategies.
CITATION STYLE
Byanova, K. L., Abelman, R., North, C. M., Christenson, S. A., & Huang, L. (2023). COPD in People with HIV: Epidemiology, Pathogenesis, Management, and Prevention Strategies. International Journal of COPD. Dove Medical Press Ltd. https://doi.org/10.2147/COPD.S388142
Mendeley helps you to discover research relevant for your work.